| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Janux Therapeutics, Inc. (JANX) has 13 insiders with recent SEC Form 4 filings, including 4 buys and 17 sells. JANX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 285.0K | $4.05M | - | |
| Other | 155.8K | $2.22M | - | |
| Other | 106.3K | $1.51M | - | |
| Other | 83.1K | $1.18M | - | |
| Dir | 79.6K | $1.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | Meyer Andrew Hollman86 | Chief Business Officer | Sale+OE | 16,665 | $30.06 | $500,986.56 | -16.9% | -50.8% | - | |
| May 1, 2025 | Meyer Andrew Hollman86 | Chief Business Officer | Sale+OE | 3,333 | $32.03 | $106,744.55 | -2.0% | -24.4% | -55.3% | |
| Apr 21, 2025 | Meyer Andrew Hollman86 | Chief Business Officer | Sale+OE | 3,334 | $30.00 | $100,020.00 | -3.9% | -11.0% | - | |
| Mar 7, 2025 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 824,041 | $30.75 | $25,342,964.88 | +2.1% | -19.2% | -54.9% | |
| Mar 3, 2025 | Meyer Andrew Hollman86 | Chief Business Officer | Sale+OE | 3,334 | $32.15 | $107,174.38 | -2.0% | -21.4% | -57.7% | |
| Feb 3, 2025 | Meyer Andrew Hollman86 | Chief Business Officer | Sale+OE | 3,334 | $42.29 | $140,999.37 | -1.3% | -29.2% | -67.2% | |
| Jan 7, 2025 | Campbell David Alan79 | President And CEO | Sell | 5,000 | $60.00 | $300,004.00 | -1.7% | -57.8% | -75.8% | |
| Jan 2, 2025 | Meyer Andrew Hollman86 | Chief Business Officer | Sell | 13,334 | $54.88 | $731,785.25 | -3.0% | -46.9% | -74.4% | |
| Dec 24, 2024 | Campbell David Alan79 | President And CEO | Sell | 25,000 | $56.19 | $1,404,805.00 | -10.3% | -43.5% | -74.5% | |
| Dec 3, 2024 | Campbell David Alan79 | President And CEO | Sell | 15,000 | $67.00 | $1,005,000.00 | -5.8% | -46.8% | -71.4% |